AIDS Dementia Complex (ADC), also known as HIV-associated neurocognitive disorder (HAND), affects individuals with HIV/AIDS, leading to cognitive decline and neurological symptoms. This condition resembles aspects of Alzheimer's Disease and other dementias but is distinct due to its association with HIV infection. ADC typically manifests with symptoms like memory loss, confusion, motor difficulties, and behavioral changes. Unlike Alzheimer's, which primarily affects older adults, ADC occurs in younger individuals living with HIV/AIDS, especially in advanced stages when the virus impacts the central nervous system. The progression of ADC varies, affecting quality of life and daily functioning. Management involves antiretroviral therapy to suppress HIV, along with supportive care to alleviate symptoms and improve neurological outcomes. Research continues to explore targeted treatments and better understanding of the disease mechanisms to improve outcomes for those affected by ADC.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States